首页
订购/客服:400-666-5481

CZC-54252

    
≥98%

CZC-54252

源叶(MedMol)
S82263 一键复制产品信息
1191911-27-9
C22H25ClN6O4S
504.9897
CZC 54252 HYDROCHLORIDE
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S82263-5mg促销
≥98%

¥122.00 ¥110.00

10 - - - -
S82263-25mg促销
≥98%

¥400.00 ¥360.00

10 - - - -
S82263-100mg促销
≥98%

¥1270.00 ¥1140.00

3 - - - -
S82263-250mg促销
≥98%

¥2210.00 ¥1990.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2, respectively. CZC-54252 attenuates G2019S LRRK2-induced human neuronal injury with an EC50 of ~1 nM. CZC-54252 has a neuroprotective activity
靶点: IC50: 1.28 nM (Wild-type LRRK2) and 1.85 nM (G2019S LRRK2);LRRK2
体外研究: CZC-54252 inhibits the activity of recombinant human wild-type LRRK2 with an IC50 ranging from ~1 to ~5 nM. The G2019S mutant is inhibited with an IC50 ranging from ~2 to ~7 nM in a TF-FRET assay. In addition, they are screened against a kinase panel of 185 kinases and exhibited good selectivity. G2019S LRRK2-induced human neuronal injury is attenuated by CZC-54252 with an EC50 of ~1 nM and fully reversed to wild-type levels by CZC-54252 at concentration of 1.6 nM
参考文献: 1. Ramsden N, et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol. 2011 Oct 21;6(10):1021-8.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.98 ml 9.901 ml 19.802 ml
5 mM 0.396 ml 1.98 ml 3.96 ml
10 mM 0.198 ml 0.99 ml 1.98 ml
50 mM 0.04 ml 0.198 ml 0.396 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×